The Hill's Genetic Testing Briefing

Rapid innovation in genetic testing is producing dramatic changes in care for 
such cancers as leukemia, colon cancer, and breast cancer. Join us for a discussion, Thursday, November 17, 2011, about 
the impact of this innovation on outcomes, side effects and utilization of resources. We will be livestreaming the event at 8:30 a.m.

Featuring remarks by:

Congressman Michael Burgess MD (R-Tex.), Vice Chair of the House Energy and Commerce Health Subcommittee

Congressman Charles Gonzalez (D-Tex.), Member of the House Energy and Commerce Health Subcommittee

Mara Bloom, Executive Director, Cancer Center, Massachusetts General Hospital

Marc Grodman, MD, President, CEO, Chairman, Bio-Reference Laboratories, Inc.

Bill McGivney, PhD, CEO, National Comprehensive Cancer Network

Simon Tripp, Senior Director, Battelle Memorial Institute


Presentation 1

Presentation 2

Presentation 3